In-vivo deposition of formoterol after inhalation of a single dose of Formoterol HFA- MDI (Chiesi), and Foradil P inhalation powder (Novartis) in COPD patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003693-14